Navigation Links
TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
Date:12/7/2009

ber 8, 2009: 7:30 AM-9:00 AM Preclinical Poster: Rapid Mobilization of Murine Hematopoietic Stem and Progenitor Cells with TG-0054, a Novel CXCR4 Antagonist (Poster Board number: III-479) Monday, December 7, 2009: 6:00 PM-8:00 PM

About TaiGen Biotechnology

TaiGen Biotechnology ( http://www.taigenbiotech.com/ ) is a leading development stage pharmaceutical company based in Taiwan with a wholly-owned subsidiary in Beijing, China. The company has a full capacity in discovery research and clinical development in China/Taiwan/US. Its current pipeline includes therapeutics for infectious diseases, diabetic complications and cancer for the worldwide market. In addition to TG-0054, Nemonoxacin, a novel broad-spectrum non-fluorinated quinolone with anti-MRSA activity and in-licensed from P&G Pharmaceuticals, achieved non-inferiority in clinical cure rate and safety profile compared with Levofloxacin in its Phase II CAP trial. The company has completed a second phase II study in diabetic foot infection to demonstrate Nemonoxacin's anti-MRSA activity with once-a-day oral dosing. TaiGen is seeking Nemonoxacin licensees for the US, EU and Japan markets. TaiGen also has HCV protease inhibitors in advanced preclinical programs to treat chronic hepatitis C infection.

    TaiGen Contact

     Dr. John Jin, VP Global Business Development
     Tel:   +886-2-2790-1861
     Email: johnjin@taigenbiotech.com.tw

SOURCE TaiGen Biotechnology Co., Ltd.


'/>"/>
SOURCE TaiGen Biotechnology Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
6. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
10. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ) has announced ... Market" report to their offering. ... focuses on the developments in the self-monitoring blood glucose ... Reimbursement analysis and the effects of competitive bidding have ... SMBG meters have been performed, based on the various ...
(Date:12/22/2014)... -- Cyberonics, Inc. (NASDAQ: CYBX ), a global ... epilepsy, today announced it will participate in the 33 rd ... 2015, in San Francisco . ... will speak at 11:00 AM Pacific Time.  A live audio ... the Investor Relations link on the Cyberonics home page at ...
(Date:12/22/2014)... ALTO, Calif. , Dec, 22, 2014 /PRNewswire/ ... a Phase 2a study of lonafarnib in patients ... study was conducted at the National Institutes of ... Maryland .  The double-blinded, randomized, placebo-controlled, dose ... mg twice daily and 200 mg twice daily ...
Breaking Medicine Technology:US Self-monitoring Blood Glucose Market 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... 2011   Radiotherapy Clinics of Georgia has announced the ... physicians of Radiotherapy Clinics of Georgia in January.  These courses ... and treatment options. All Prostate Cancer Lecture Series ... a light dinner at 5 p.m. followed by a lecture ...
... Md., Dec. 16, 2011 The U.S. Food and Drug ... heart of children with heart failure to help keep them ... found. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... Pediatric System, made by a German company, Berlin Heart. The ...
Cached Medicine Technology:Radiotherapy Clinics of Georgia Present Prostate Cancer Lecture Series 2FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure 2FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure 3
(Date:12/24/2014)... 24, 2014 The Healthy Home Company has ... raise families. In-Vest USA is dedicated to ... – our first responders. Today, these two organizations have joined ... providing them with body armor through In-Vest’s USA’s Bless the ... that happened this past week in New York. ...
(Date:12/24/2014)... There’s a lot going on with The Affordable Care ... control of the Senate as well as the House, a ... lawsuit has been brought against President Obama by the House, ... have resulted in changes to the law without the approval ... place to weigh the validity of subsidies provided to low ...
(Date:12/24/2014)... “ Relax Melodies ” was featured on NewsWatch ... latest and coolest mobile applications on the iOS, Android, ... and host of NewsWatch, conducted the app review and ... they can fall asleep. , According to the National ... some sort of difficulty sleeping. Since that’s a huge ...
(Date:12/24/2014)... 2014 Dr. Ronald Receveur, a ... placing dental implants in a day, has ... of overusing teeth-whitening treatments. , In his blog ... Dr. Receveur writes that overusing teeth-whitening treatments can lead ... to enamel. , “Because teeth-whitening treatments are ...
(Date:12/24/2014)... year, more than one-third of the more than 10,000 ... extreme heat conditions, according to recent federal statistics. ... the leading cause of heat-related illness among Americans, but ... infections, also put older people at higher risk for ... help health care systems anticipate and perhaps prevent many ...
Breaking Medicine News(10 mins):Health News:The Healthy Home Company and In-Vest USA Team Up to Save the Lives of Law Enforcement 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 3Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 3Health News:Heat Stroke, Kidney Failure Help Drive Illnesses From Extreme Heat 2
... Key New Products Including Completing CE Mark, ... -, TSX Venture Exchange: NVC,VANCOUVER, April ... that it has completed a previously announced non-brokered private ... of $0.21 per unit for aggregate gross proceeds of ...
... Copenhagen, Denmark, Friday 24 April: HIV positive and ... transplant, according to new research presented today at EASL ... the Study of Liver in Copenhagen, Denmark. , The ... 1 and 5 years between HIV negative and HIV ...
... highest standards in the security industry , ... Freeport, ... Inc. is pleased to announce it has once again been awarded ... Alarm Association (CSAA)., , , , ,There are approximately 2,700 central ...
... community and helps individuals with vision care and restoration. , ... ... Christian is an affluent, prestigious, private high school, nestled in the ... their efforts and dedication toward educating America,s youth, by donating several ...
... much as younger ones, , , THURSDAY, April 23 (HealthDay ... older than 50 -- even if they,ve had several ... level of risk as younger women, European researchers contend. ... repeating smear tests in women 60 to 65 years ...
... MINNEAPOLIS, April 23 As federal policymakers pursue healthcare ... health promotion and disease prevention will be critically evaluated. ... more than 40 of North America,s top medical schools ... original scientific research in the area of integrative medicine. ...
Cached Medicine News:Health News:Neovasc Completes $2 Million Non-Brokered Private Placement 2Health News:Neovasc Completes $2 Million Non-Brokered Private Placement 3Health News:HIV positive and HIV negative patients have similar survival rates following liver transplant 2Health News:New York Merchants Protective Co. Renews CSAA Five Diamond Certification 2Health News:New York Merchants Protective Co. Renews CSAA Five Diamond Certification 3Health News:Khanna Institute Supports Oaks Christian School's Annual Fundraiser 2Health News:Don't Lower Age for Cervical Cancer Test, Study Urges 2Health News:Advancements in Integrative Medicine Research to Be Evaluated by Scientists From Leading International Academic Health Centers 2
The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... uses a classical distance-independent measuring principle which ... The size of the mire image is ... and the measured object; 2. The resulting ... the Ophthalmometer and the measured object; 3. ...
Medicine Products: